Team:Penn/ProjectResults
From 2012.igem.org
(Created page with "{{:Team:Penn/Template/Site}} <html> <style type="text/css"> .all{ width:1000px; margin:0 auto;} .ImageBorder {border: 3px solid #ffffff;margin: 0 0 20px 0;} .und{font-size:20px;c...")
Newer edit →
Revision as of 12:03, 26 October 2012
What if you could combine spatial targeting and cellular targeting into the same therapeutic? This idea is unprecedented but would allow for precise targeting of specific cells within a specific area, leaving healthy tissue intact and keeping side effects to a minimum.
The 2012 Penn iGEM team has engineered a novel platform for targeted therapeutics which employs simultaneous spatial and cellular targeting. We have achieved spatial (and temporal) targeting with a blue light-switchable transgene expression system, and cellular targeting through display of an antibody-mimetic protein on the surface of E. coli for the first time.
As a proof of concept, we applied our system to the treatment of cancer, a disease in which spatial and cellular targeting are of utmost importance. We displayed a high-affinity antibody-mimetic protein which targets Human Epidermal Growth Factor Receptor 2 (HER2), a protein commonly overexpressed in cancer cells. We combined this cellular targeting with a light-activated cytotoxic protein delivery system to successfully target and kill breast cancer cells.